Biofrontera Inc.

NASDAQ (USD): Biofrontera Inc. (BFRI)

Last Price

1.09

Today's Change

0.00 (0.00%)

Day's Change

1.04 - 1.14

Trading Volume

163,427

Overview

Market Cap

8 Million

Shares Outstanding

7 Million

Avg Volume

2,986,975

Avg Price (50 Days)

0.96

Avg Price (200 Days)

1.16

PE Ratio

0.95

EPS

1.16

Earnings Announcement

13-Mar-2025

Previous Close

1.09

Open

1.04

Day's Range

1.04 - 1.14

Year Range

0.61 - 3.9

Trading Volume

167,654

Price Change Highlight

1 Day Change

0.88%

5 Day Change

1.81%

1 Month Change

9.95%

3 Month Change

2.76%

6 Month Change

30.89%

Ytd Change

0.87%

1 Year Change

-60.73%

3 Year Change

-99.21%

5 Year Change

-98.75%

10 Year Change

-98.75%

Max Change

-98.75%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment